Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Menicon Co ( (JP:7780) ) has provided an announcement.
Menicon has revised the accounting treatment of additional earn-out consideration tied to its acquisition of Itabashi Trading, following a renewed review by its auditing firm. Rather than recognizing up to JPY 3.52 billion in goodwill amortization as an extraordinary loss in the year ending March 2027, the company will book related expenses as selling, general and administrative costs, with up to JPY 500 million recorded in the year ending March 2026.
This reclassification will affect operating profit and profit levels in the current fiscal year by shifting costs into operating expenses, but Menicon maintains that consolidated results should remain in line with the financial forecast announced at the start of the year. The company does not plan to revise its earnings outlook at this time and will provide further disclosure if additional material developments arise.
The most recent analyst rating on (JP:7780) stock is a Buy with a Yen1863.00 price target. To see the full list of analyst forecasts on Menicon Co stock, see the JP:7780 Stock Forecast page.
More about Menicon Co
Menicon Co., Ltd., listed on the TSE Prime and NSE Premier markets, operates in the broader healthcare and vision-care industry. The company has been expanding through acquisitions, including converting Itabashi Trading Co., Ltd. into a subsidiary, and manages its portfolio with attention to accounting treatment and financial forecast stability.
YTD Price Performance: 5.07%
Average Trading Volume: 270,578
Technical Sentiment Signal: Hold
Current Market Cap: Yen127.7B
For an in-depth examination of 7780 stock, go to TipRanks’ Overview page.

